•
Adverse events
•
No adherence to medication
•
Drug interactions
•
Frailty
•
Disability
•
Falls
•
Mortality
•
Cognitive impairment
Gnjdic D et al. J Clin Epidemiol 2012;65: 989e995; Maher RL et al. Expert Opin Drug Saf 2014;13:57-65
Risks of polypharmacy
SAEU.CAB.16.07.0040j
